SG
VIVS

Societe Generale’s VivoSim Labs VIVS Stock Holding History

Societe Generale’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$75K Buy
+84
New +$56.3K ﹤0.01% 2429

Other funds holding VIVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Societe Generale's VIVS Position: Q2 2016 in Review

Societe Generale opened a new position in VivoSim Labs (VIVS) in Q2 2016: 84 shares worth $75K. The stake represents ﹤0.01% of the portfolio and ranks #2429 among its holdings.

115 funds tracked by Wall St. Rank hold VIVS as of Q2 2016.

  • Societe Generale held 84 shares of VivoSim Labs worth $75K as of Q2 2016.
  • VivoSim Labs was a new Societe Generale position in Q2 2016.
  • VivoSim Labs made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #2429 holding.
  • 115 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.